ARTICLE | Company News
Amorfix, JSW Lifesciences GmbH deal
June 18, 2012 7:00 AM UTC
CRO JSW Lifesciences received an exclusive, worldwide license to market and to use as a service Amorfix's Amorfix Aggregated Abeta Assay (A4) for preclinical research in Alzheimer's disease (AD). Amor...